title: Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine.
authors.affiliation: Laboratoire d'hématologie, Centre de Biologie Pathologie, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: J
authors.initials: J
authors.lastname: Desoutter
authors.affiliation: Service d'hématologie clinique, Hôpital Saint Antoine, Université Paris 6, APHP, Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Gay
authors.affiliation: Service d'hématologie clinique, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: C
authors.initials: C
authors.lastname: Berthon
authors.affiliation: Service d'hématologie clinique, Hôpital d'Avicenne, Université Paris 13, Bobigny, France.
authors.forename: L
authors.initials: L
authors.lastname: Ades
authors.affiliation: Service d'hématologie clinique, CHU Amiens-Picardie, Amiens, France.
authors.forename: B
authors.initials: B
authors.lastname: Gruson
authors.affiliation: Laboratoire d'hématologie, Centre de Biologie Pathologie, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: S
authors.initials: S
authors.lastname: Geffroy
authors.affiliation: Service d'hématologie clinique, Hôpital de Roubaix, Roubaix, France.
authors.forename: I
authors.initials: I
authors.lastname: Plantier
authors.affiliation: Laboratoire d'hématologie, Centre de Biologie Pathologie, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: A
authors.initials: A
authors.lastname: Marceau
authors.affiliation: Laboratoire d'hématologie, Centre de Biologie Pathologie, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: N
authors.initials: N
authors.lastname: Helevaut
authors.affiliation: Service d'hématologie clinique, Hôpital de Valenciennes, Valenciennes, France.
authors.forename: J
authors.initials: J
authors.lastname: Fernandes
authors.affiliation: Service d'hématologie clinique, Hôpital de Dunkerque, Dunkerque, France.
authors.forename: M
authors.initials: M
authors.lastname: Bemba
authors.affiliation: Service d'hématologie clinique, Hôpital de Lens, Lens, France.
authors.forename: L
authors.initials: L
authors.lastname: Stalnikiewicz
authors.affiliation: Laboratoire d'hématologie, Centre de Biologie Pathologie, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: C
authors.initials: C
authors.lastname: Frimat
authors.affiliation: Unités de Biostatistiques, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: J
authors.initials: J
authors.lastname: Labreuche
authors.affiliation: Laboratoire d'hématologie, Centre de Biologie Pathologie, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: O
authors.initials: O
authors.lastname: Nibourel
authors.affiliation: Laboratoire d'hématologie, Centre de Biologie Pathologie, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: C
authors.initials: C
authors.lastname: Roumier
authors.affiliation: Plateforme de génomique structurale et fonctionnelle, IFR-114, Université Lille 2, Lille, France.
authors.forename: M
authors.initials: M
authors.lastname: Figeac
authors.affiliation: Service d'hématologie clinique, Hôpital Saint-Louis, Université Paris 7, APHP, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Fenaux
authors.affiliation: Service d'hématologie clinique, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: B
authors.initials: B
authors.lastname: Quesnel
authors.affiliation: Laboratoire d'hématologie, Centre de Biologie Pathologie, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: A
authors.initials: A
authors.lastname: Renneville
authors.affiliation: Unités de Biostatistiques, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: A
authors.initials: A
authors.lastname: Duhamel
authors.affiliation: Laboratoire d'hématologie, Centre de Biologie Pathologie, CHRU Lille, Université Lille 2, Lille, France.
authors.forename: C
authors.initials: C
authors.lastname: Preudhomme
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001374:Azacitidine / Q000627:therapeutic use*; D005260:Female; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011379:Prognosis; D015996:Survival Rate
chemical_list: D001374:Azacitidine